Table A

Table B

Table C

Table A Key baseline patient characteristics by diagnosis (n=28,825) [posted as supplied by author]

Characteristic

STEMI

NSTEMI

Unstable angina

P value

N

9833

9007

9985

 

Median age (years) (IQR)

64 (54, 74)

68 (57, 77)

66 (56, 75)

<0.001

Men (%)

6919 (71)

5939 (66)

6262 (63)

<0.001

Killip class (%)





I

7715 (80)

6833 (78)

8335 (86)

<0.001 (4 ´ 3 comparison)

II

1334 (14)

1349 (15)

1057 (11)

III

386 (4.0)

543 (6.2)

213 (2.2)

IV

193 (2.0)

73 (0.8)

62 (0.6)

Medical history (%)

       

Stroke

642 (6.6)

899 (10)

831 (8.4)

<0.001

PCI

727 (7.4)

1228 (14)

2420 (24)

<0.001

CABG

487 (5.0)

1183 (13)

1854 (19)

<0.001

Angiogram for CAD

1271 (13)

2467 (28)

4019 (43)

<0.001

Positive stress test

389 (4.0)

864 (9.8)

1704 (17)

<0.001

Myocardial infarction

1860 (19)

2836 (32)

4039 (41)

<0.001

Hypertension

5004 (57)

5491 (61)

6495 (66)

<0.001

Diabetes mellitus

2077 (21)

2424 (27)

2545 (26)

<0.001

CABG, coronary artery bypass grafting; CAD, coronary artery disease; IQR, interquartile range; NSTEMI, non-ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction

 

Table B Geographical trends in the use of invasive procedures in hospitals with and without access to a catheterization laboratory [posted as supplied by author]

 

Catheterization laboratory

N=22,096

No catheterization laboratory

N=6729

P value

PCI

     

Overall (%)

8941 (41)

253 (3.9)

<0.001

USA (%)

2199 (40)

123 (10)

<0.001

Europe (%)

4523 (48)

60 (2.0)

<0.001

Australia/New Zealand/Canada (%)

746 (28)

18 (1.3)

<0.001

Argentina/Brazil (%)

1473 (32)

52 (5.7)

<0.001

CABG

     

Overall (%)

1554 (7.1)

46 (0.7)

<0.001

USA (%)

589 (11)

19 (1.6)

<0.001

Europe (%)

340 (3.7)

6 (0.2)

<0.001

Australia/New Zealand/Canada (%)

169 (6.5)

12 (0.9)

<0.001

Argentina/Brazil (%)

456 (10)

9 (1.0)

<0.001

PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting

 

Table C Use of percutaneous coronary intervention and coronary artery bypass grafting according to diagnosis and access to a catheterization laboratory [posted as supplied by author]

 

STEMI

NSTEMI

Unstable angina

 

Cath+

Cath-

Cath+

Cath-

Cath+

Cath-

N

7847

1986

6991

2016

7258

2727

PCI (%)

4238 (54)

83 (4.3)*

2667 (38)

88 (4.6)*

2036 (28)

82 (3.1)*

CABG (%)

371 (4.8)

7 (0.4)*

690 (9.9)

17 (0.9)*

493 (6.9)

22 (0.8)*

CABG, coronary artery bypass grafting; cath+, hospitals with access to catheterization facilities; cath-, hospitals without access to catheterization facilities; NSTEMI, non-ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction

*P<0.001





Access jobs at BMJ Careers
Whats new online at Student 

BMJ